Victory Capital Management Inc. Has $125.22 Million Stock Position in Tenet Healthcare Corporation $THC

Victory Capital Management Inc. decreased its position in Tenet Healthcare Corporation (NYSE:THC) by 0.3% in the third quarter, according to its most recent 13F filing with the SEC. The firm owned 616,699 shares of the company’s stock after selling 2,165 shares during the period. Victory Capital Management Inc.’s holdings in Tenet Healthcare were worth $125,215,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also modified their holdings of THC. Focus Partners Advisor Solutions LLC boosted its position in Tenet Healthcare by 104.9% during the 3rd quarter. Focus Partners Advisor Solutions LLC now owns 7,569 shares of the company’s stock worth $1,496,000 after acquiring an additional 3,875 shares during the period. Journey Strategic Wealth LLC boosted its stake in shares of Tenet Healthcare by 25.3% during the 3rd quarter. Journey Strategic Wealth LLC now owns 1,714 shares of the company’s stock valued at $348,000 after buying an additional 346 shares during the period. Sierra Summit Advisors LLC acquired a new position in shares of Tenet Healthcare in the third quarter worth $765,000. Quantbot Technologies LP grew its stake in Tenet Healthcare by 4,442.0% in the third quarter. Quantbot Technologies LP now owns 16,851 shares of the company’s stock valued at $3,421,000 after purchasing an additional 16,480 shares in the last quarter. Finally, Aster Capital Management DIFC Ltd bought a new stake in shares of Tenet Healthcare in the 3rd quarter valued at approximately $86,000. Hedge funds and other institutional investors own 95.44% of the company’s stock.

Insider Activity

In related news, insider R. Scott Ramsey sold 8,017 shares of the company’s stock in a transaction on Monday, March 2nd. The stock was sold at an average price of $232.70, for a total value of $1,865,555.90. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, EVP Thomas W. Arnst sold 24,000 shares of Tenet Healthcare stock in a transaction on Monday, March 2nd. The stock was sold at an average price of $234.04, for a total transaction of $5,616,960.00. Following the sale, the executive vice president owned 8,012 shares in the company, valued at $1,875,128.48. This represents a 74.97% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last ninety days, insiders have sold 34,195 shares of company stock worth $7,912,606. Company insiders own 0.81% of the company’s stock.

Tenet Healthcare Stock Up 0.5%

Shares of THC stock opened at $244.10 on Thursday. Tenet Healthcare Corporation has a 12 month low of $109.82 and a 12 month high of $245.98. The company has a quick ratio of 1.68, a current ratio of 1.76 and a debt-to-equity ratio of 2.18. The firm has a market cap of $21.23 billion, a PE ratio of 15.76, a price-to-earnings-growth ratio of 1.20 and a beta of 1.39. The stock has a 50 day moving average of $208.54 and a 200-day moving average of $201.39.

Tenet Healthcare (NYSE:THC) last announced its earnings results on Wednesday, February 11th. The company reported $4.70 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $4.08 by $0.62. The business had revenue of $5.53 billion for the quarter, compared to analyst estimates of $5.47 billion. Tenet Healthcare had a net margin of 6.60% and a return on equity of 26.33%. Tenet Healthcare’s revenue was up 8.9% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $3.44 earnings per share. Tenet Healthcare has set its FY 2026 guidance at 16.190-18.470 EPS. On average, equities analysts predict that Tenet Healthcare Corporation will post 12.24 EPS for the current year.

Analysts Set New Price Targets

Several brokerages have recently commented on THC. Cantor Fitzgerald restated an “overweight” rating on shares of Tenet Healthcare in a research note on Wednesday. TD Cowen restated a “buy” rating on shares of Tenet Healthcare in a report on Thursday, February 12th. JPMorgan Chase & Co. increased their price objective on Tenet Healthcare from $200.00 to $230.00 and gave the company an “overweight” rating in a report on Thursday, November 13th. Leerink Partners upped their target price on Tenet Healthcare from $255.00 to $264.00 and gave the stock an “outperform” rating in a research report on Friday, February 20th. Finally, Wells Fargo & Company restated an “overweight” rating and issued a $265.00 price objective on shares of Tenet Healthcare in a research note on Monday, February 16th. One investment analyst has rated the stock with a Strong Buy rating, eighteen have assigned a Buy rating and three have given a Hold rating to the company’s stock. According to MarketBeat.com, Tenet Healthcare presently has a consensus rating of “Moderate Buy” and an average price target of $247.67.

About Tenet Healthcare

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.